Anti-Cancer Drug Prices: Proven Ways to Ensure Affordability
Anti-cancer drug prices are being monitored closely to ensure affordability for patients. Learn more about the recent government measures.
Anti-Cancer Drug Prices Cut: Quick Relief for Patients
Anti-cancer drug prices are now lower, making treatments more affordable for patients in India.
Marksans revenue growth: Proven strategies for success
Marksans revenue growth highlights a remarkable 3.8 times increase driven by strategic acquisitions.
Gland Pharma USFDA Approval: A Proven Milestone in Pharma
Gland Pharma USFDA approval marks a significant achievement for the pharmaceutical industry, enhancing treatment options.
Expired Amphotericin B approvals: Worst Emergency Approvals
Expired Amphotericin B approvals have been slammed by the SC, raising concerns over the DCGI’s emergency protocols.
Anti-Cancer Drug Prices: Clear Changes You Need to Know
Anti-cancer drug prices are revised by NPPA, effective November 9. Discover the new rates and what it means for patients.
Pancreatic cancer drug: Proven treatment doubles survival rates
Pancreatic cancer drug shows promise with initial approval in Europe, potentially doubling patient survival rates.
Drug Price Regulation: The Best Proven Solutions for Fair Pricing
Drug price regulation is essential for ensuring fair access to medicines and medical devices. Discover the latest insights.
Drug Price-Fixing Settlements: Worth Exploring Your Compensation Options
Drug price-fixing settlements could lead to compensation for Maine residents. Find out how you may qualify today.
Medicine price gaps: The Worst Proven Issues in Karnataka
Medicine price gaps are causing significant issues in Karnataka, prompting the state to seek intervention from the central government.





